top of page
Business Discussion

SSC Bio Ltd utilises key experience in advanced biological medicines, microbiology and biobanking in support of researchers, product developers, policy makers and other organisations. Its activity is based on the extensive knowledge and experience of its CEO Professor Glyn Stacey acquired over more than 30 years and extends to a network of connections with high level expertise.

Key competencies and knowledge areas: 

  • Cell substrates for the manufacture of biologicals.

  • Safety and quality issues for cells used in cell therapy, manufacture of biologicals and the development of cell-based assays and genetic reference materials.

  • Biobanking of diverse biomaterials e.g., animal cell lines, plant cultures, gametes.

  • Cryopreservation science and long term storage of biological materials.

  • International best practice guidance on cell and stem cell culture.

Professional employment:

  • Registered professional pathologist specialising in microbiology.

  • Director SSC Bio Ltd.

  • Director International Stem Cell Banking Initiative.

  • Director for the UK Stem Cell Bank (2003-2017)

  • Senior scientist and divisional head at the National Institute for Biological Standards and Control in the UK (1998-2017)

  • Principal investigator and advisory board member for numerous UK, EU and international R&D projects in regenerative medicines, stem cell research and toxicology

dads pic 2020.JPG

Key external positions held:

  • International Alliance for Biological Standardisation Gene and Cell Therapy Committee (2013-present)

  • Visiting Professor at the University of Bedfordshire (2007-present) and University of Suffolk (2017-present)

  • UK Department of Health committee for the Safety of Blood Tissues and Organs (SaBTO) (2014-2015)

  • Coordinator for the NIBSC Stem Cell Open Forum (1999-2001),

bottom of page